Cardiff Oncology, Inc. (CRDF)
NASDAQ
Market Cap
$163.63M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
143 of 963
Rank in Industry
99 of 552
Largest Insider Buys in Sector
CRDF Stock Price History Chart
CRDF Stock Performance
About Cardiff Oncology, Inc.
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company's TROV-053 is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Insider Activity of Cardiff Oncology, Inc.
Over the last 12 months, insiders at Cardiff Oncology, Inc. have bought $981,299 and sold $0 worth of Cardiff Oncology, Inc. stock.
On average, over the past 5 years, insiders at Cardiff Oncology, Inc. have bought $720,060 and sold $657,020 worth of stock each year.
Highest buying activity among insiders over the last 12 months: PACE GARY W (director) — $3.93M.
The last purchase of 361,615 shares for transaction amount of $940,199 was made by PACE GARY W (director) on 2024‑12‑11.
List of Insider Buy and Sell Transactions, Cardiff Oncology, Inc.
| 2024-12-11 | director | 361,615 0.5003% | $2.60 | $940,199 | +23.08% | |||
| 2023-12-19 | director | 30,000 0.0671% | $1.37 | $41,100 | +88.32% | |||
| 2022-11-25 | Chief Executive Officer | 10,000 0.0236% | $1.43 | $14,300 | +14.39% | |||
| 2022-09-19 | director | 15,000 0.0327% | $1.64 | $24,525 | -7.51% | |||
| 2022-09-16 | Chief Financial Officer | 30,000 0.0682% | $1.56 | $46,710 | +1.27% | |||
| 2022-09-16 | director | 13,000 0.0296% | $1.56 | $20,233 | +1.27% | |||
| 2022-09-15 | director | 150,000 0.3544% | $1.71 | $256,500 | -4.49% | |||
| 2022-09-15 | director | 10,000 0.0237% | $1.72 | $17,168 | -4.49% | |||
| 2021-09-21 | director | 30,000 0.0764% | $6.75 | $202,500 | -58.36% | |||
| 2021-09-10 | Chief Financial Officer | 30,000 0.0779% | $6.47 | $194,000 | -54.92% | |||
| 2021-03-26 | director | 2,900 0.0081% | $10.32 | $29,933 | -37.55% | |||
| 2021-03-23 | director | 10,000 0.0273% | $10.23 | $102,300 | -37.74% | |||
| 2021-03-23 | director | 2,370 0.0066% | $10.42 | $24,689 | -37.74% | |||
| 2021-03-23 | Chief Executive Officer | 965 0.0027% | $10.34 | $9,980 | -37.74% | |||
| 2021-03-23 | Exec. VP and COO | 960 0.0026% | $10.31 | $9,898 | -37.74% | |||
| 2021-03-22 | director | 3,000 0.0083% | $10.95 | $32,850 | -40.92% | |||
| 2021-03-19 | director | 4,000 0.0101% | $10.82 | $43,271 | -45.21% | |||
| 2021-03-18 | director | 3,000 0.0083% | $10.55 | $31,660 | -38.95% | |||
| 2021-03-04 | director | 1,500 0.0041% | $9.27 | $13,898 | -29.09% | |||
| 2020-11-23 | Sale | Exec. VP and COO | 35,321 0.147% | $18.60 | $657,020 | -57.83% |
Insider Historical Profitability
94.51%
| PACE GARY W | director | 1059376 2.0718% | $3.20 | 9 | 0 | +78.54% |
| Hunter Robert Merrill | 10 percent owner | 5065004 9.9054% | $3.20 | 1 | 0 | |
| BRIDGER MANAGEMENT, LLC | 2968115 5.8046% | $3.20 | 7 | 0 | <0.0001% | |
| Sheinerman Kira | director | 909090 1.7779% | $3.20 | 1 | 0 | |
| CERRONE GABRIEL | director | 719526 1.4071% | $3.20 | 5 | 0 | |
| White Lale | director | 113788 0.2225% | $3.20 | 2 | 0 | +295.89% |
| Levine James E. | Chief Financial Officer | 60000 0.1173% | $3.20 | 2 | 0 | <0.0001% |
| Tennant Stanley | director | 28839 0.0564% | $3.20 | 6 | 1 | <0.0001% |
| Erlander Mark | Chief Executive Officer | 24481 0.0479% | $3.20 | 4 | 0 | +129.51% |
| Markin Rodney S | director | 23879 0.0467% | $3.20 | 3 | 0 | +180.98% |
| JACOB GARY S | director | 21922 0.0429% | $3.20 | 2 | 0 | +280.78% |
| ZANIBONI STEVE | CFO | 21329 0.0417% | $3.20 | 2 | 0 | <0.0001% |
| SCHUH ANTONIUS | CEO | 20000 0.0391% | $3.20 | 1 | 0 | <0.0001% |
| ADAMS THOMAS PHD | director | 18875 0.0369% | $3.20 | 1 | 2 | +599.3% |
| Armitage James O | director | 13000 0.0254% | $3.20 | 3 | 0 | +185.12% |
| BRANCACCIO JOHN P | director | 12260 0.024% | $3.20 | 3 | 0 | +178.34% |
| TANNENBAUM RENEE P | director | 10000 0.0196% | $3.20 | 1 | 0 | <0.0001% |
| Kelemen Vicki | Exec. VP and COO | 6053 0.0118% | $3.20 | 1 | 1 | <0.0001% |
| WELCH WILLIAM J | CEO | 4750 0.0093% | $3.20 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| The Vanguard Group | $10.26M | 4.3 | 1.92M | +0.49% | +$50,559.12 | <0.0001 | |
| Laurion Capital Management LP | $4.96M | 2.08 | 928,717 | +28.61% | +$1.1M | 0.04 | |
| Millennium Management LLC | $3.65M | 1.53 | 683,299 | New | +$3.65M | <0.01 | |
| BlackRock | $3.62M | 1.52 | 677,458 | -5.45% | -$208,430.90 | <0.0001 | |
| MAI Capital Management, LLC | $2.94M | 1.23 | 551,124 | +45.3% | +$917,486.71 | 0.03 | |
| Marshall Wace | $2.32M | 0.97 | 434,582 | New | +$2.32M | <0.01 | |
| Geode Capital Management | $2.32M | 0.97 | 434,833 | +2.53% | +$57,296.41 | <0.0001 | |
| Goldman Sachs | $1.53M | 0.64 | 285,874 | New | +$1.53M | <0.0001 | |
| Assenagon Asset Management S.A. | $1.35M | 0.57 | 252,982 | New | +$1.35M | <0.01 | |
| Blair William Co Il | $919,441.00 | 0.39 | 172,180 | +32.45% | +$225,241.15 | <0.01 | |
| Eam Investors | $864,562.00 | 0.36 | 161,903 | New | +$864,562.00 | 0.05 | |
| State Street | $747,306.00 | 0.31 | 139,945 | 0% | +$0 | <0.0001 | |
| Qube Research & Technologies | $679,691.00 | 0.29 | 127,283 | +244,675% | +$679,413.32 | <0.01 | |
| Man Group Plc | $602,117.00 | 0.25 | 112,756 | New | +$602,117.00 | <0.01 | |
| Renaissance Technologies | $460,000.00 | 0.19 | 86,100 | -26.03% | -$161,881.53 | <0.01 | |
| Northern Trust | $456,639.00 | 0.19 | 85,513 | +19.79% | +$75,438.11 | <0.0001 | |
| Citigroup | $443,829.00 | 0.19 | 83,114 | New | +$443,829.00 | <0.0001 | |
| Susquehanna International Group | $444,571.00 | 0.19 | 83,253 | +265.45% | +$322,920.47 | <0.0001 | |
| Morgan Stanley | $424,129.00 | 0.18 | 79,425 | +421.16% | +$342,747.50 | <0.0001 | |
| Jane Street Capital | $386,211.00 | 0.16 | 72,324 | +233.46% | +$270,391.49 | <0.0001 | |
| Hrt Financial Llc | $362,000.00 | 0.15 | 67,889 | New | +$362,000.00 | <0.01 | |
| Bank of America | $345,631.00 | 0.15 | 64,725 | +30% | +$79,763.46 | <0.0001 | |
| OMERS | $272,874.00 | 0.11 | 51,100 | New | +$272,874.00 | <0.01 | |
| Capstone Investment Advisors | $273,355.00 | 0.11 | 51,190 | 0% | +$0 | 0.01 | |
| Point72 Asia Singapore Pte Ltd | $266,423.00 | 0.11 | 49,892 | New | +$266,423.00 | 0.03 | |
| Callan Capital | $228,269.00 | 0.1 | 42,747 | +37.24% | +$61,944.00 | 0.02 | |
| Creative Planning | $214,940.00 | 0.09 | 40,251 | +57.85% | +$78,770.21 | <0.0001 | |
| Elkhorn Partners Limited Partnership | $208,000.00 | 0.09 | 39,000 | -40.46% | -$141,333.33 | 0.15 | |
| Simplex Trading Llc | $200,000.00 | 0.08 | 37,591 | New | +$200,000.00 | 0.01 | |
| T. Rowe Price | $195,000.00 | 0.08 | 36,500 | 0% | +$0 | <0.0001 | |
| Cubist Systematic Strategies | $172,423.00 | 0.07 | 32,289 | New | +$172,423.00 | <0.01 | |
| Brevan Howard Capital Management Lp | $173,027.00 | 0.07 | 32,402 | New | +$173,027.00 | 0.01 | |
| Y Intercept Hong Kong Ltd | $157,338.00 | 0.07 | 29,464 | New | +$157,338.00 | 0.01 | |
| American Century Investments | $121,880.00 | 0.05 | 22,824 | New | +$121,880.00 | <0.0001 | |
| Two Sigma | $122,644.00 | 0.05 | 22,967 | -25.11% | -$41,118.07 | <0.0001 | |
| Two Sigma Advisers LP | $115,878.00 | 0.05 | 21,700 | -44.64% | -$93,450.00 | <0.0001 | |
| Integrated Wealth Concepts Llc | $117,480.00 | 0.05 | 22,000 | New | +$117,480.00 | <0.01 | |
| Bank of Montreal | $44,200.00 | 0.05 | 22,100 | New | +$44,200.00 | <0.0001 | |
| Hightower Advisors | $96,000.00 | 0.04 | 18,000 | +17.39% | +$14,224.00 | <0.0001 | |
| Squarepoint Ops LLC | $93,519.00 | 0.04 | 17,513 | New | +$93,519.00 | <0.0001 | |
| Wolverine Trading | $87,934.00 | 0.04 | 16,467 | New | +$87,934.00 | <0.01 | |
| Charles Schwab | $87,571.00 | 0.04 | 16,399 | 0% | +$0 | <0.0001 | |
| Sherbrooke Park Advisers Llc | $86,230.00 | 0.04 | 16,148 | New | +$86,230.00 | 0.02 | |
| Findec Wealth Services Inc | $85,440.00 | 0.04 | 16,000 | 0% | +$0 | 0.08 | |
| UNITED BANK | $82,770.00 | 0.04 | 15,500 | +19.23% | +$13,350.00 | 0.01 | |
| Royal Bank of Canada | $80,000.00 | 0.03 | 15,000 | +3,118.88% | +$77,514.67 | <0.0001 | |
| Gladstone Institutional Advisory Llc | $80,100.00 | 0.03 | 15,000 | 0% | +$0 | 0.01 | |
| Marathon Trading Investment Management Llc | $80,100.00 | 0.03 | 15,000 | New | +$80,100.00 | 0.02 | |
| Atom Investors Lp | $81,691.00 | 0.03 | 15,298 | -15.11% | -$14,535.42 | 0.01 | |
| Dimensional Fund Advisors | $75,860.00 | 0.03 | 14,206 | 0% | +$0 | <0.0001 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.